Applications Published 8 November 2000
Published: 25-Jun-2001
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Sesquiterpene synthases from grand fir Abies Grandis and methods of use
Washington State University Research Foundation 1049370*Cosmetic or pharmaceutical preparations with a less sticky feel, containing glycerin esters of alpha-hydroxy carboxylic acids and saturated fatty acids
Beiersdorf 1049453*Cosmetic and dermatological preparations containing higher electrolyte concentrations
Beiersdorf 1049454*Bioactive glass treatment of inflammation in skin conditions
Usbiomaterials 1049457*Lyophilisation method for sustained-release preparations
Takeda Chemical Industry 1047458*Oral liquid compsns
Applied Analytical Industries 1047459*Method of the prophylactic treatment of mastitis
Astacarotene 1049460*Use of topical preparations of glycerin trinitrate and lanolin for the treatment of erectile dysfunction
Futura Medical 1049461*Choline esters of fatty acids and their use in treatment of stroke
Neuromedica 1049462*Use of FC101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases
University of South Carolina 1049463*Use of citrus limonoids and flavonoids as well as tocopherols for the treatment of cancer
KGK Synergise; Carroll, Margaret Aileen 1049464*Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer
Max-Planck-Gesellschaft zur Forderung der Wissenschaft 1049465*Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
Merck Sharp and Dohme 1049466*Celecoxib compsns
GD Searle 1049467*Utilisation of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
Aventis Pharma Deutschland 1049468*Biodegradable polymer matrices for sustained delivery of anaesthetics
Korea Research Institute of Chemical Technology 1049469*Extended release tiagibine formulations with reduced side-effects
Abbott Laboratories 1049470*Compsns and methods for treating atopic dermatitis, angioedema and other disorders using antihistamines and glucocorticoids
Schering 1049471*Antagonists of gonadotrophin releasing hormone
Merck 1049472*Pyrimidin 3-oxide compounds suitable for the treatment of pathologies of the skeletal muscle, in particular for the treatment of the hypokalemic paralysis
Paolini, Moreno; Tricarico, Domenico 1049473*Cannabimimetic lipid amides as useful medications
Makriyannis, Alexandros; Khanolkar, Atmaram; Goutopoulos, Andreas 1049474*Kinesin motor modulators derived from the marine sponge Adocia
The Regents of the University of California 1049475*Pharmaceutical compsns for mucolysis and treatment of inflammation
Clarion Pharmaceuticals 1049476*Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications
A+ Science Invest 1049477*Compsn containing propargylamine for enhancing cancer therapy
University of Saskatchewan Technologies 1049478*Analgesic from snake venom
Shulov Institute for Venom Research 1049479*Herbal anti-viral agent
Rhinopharma 1049480*Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
Arizona Board of Regents 1049481*Method of producing elastin, elastin-based biomaterials and tropoelastin materials
Sisters of Providence in Oregon 1049482*Method for treating inflammatory diseases using heat shock proteins
National Jewish Medical and Research Centre 1049483*Method of using IL-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
Genetics Institute 1049484*Enhancement of haematopoetic cells
Genzyme Corporation 1049485*Method for treating acute intermittent porphyria (AIP) and other porphyric diseases
Hemebiotech 1049487*Method of and compsns for immunisation with the Psuedomonas V antigen
MCW Research Foundation 1049488*Agent capable of modulating a glycophospholipid-associated activity thus affecting an immune disorder
University of Bristol 1049489*Method of inhibiting CD95-independent apoptosis in AIDS.
Deutsches Krebforschunszentrum Stiftung des oeffentlichen Rechts 1049490*Gene therapy of tumours using non-viral delivery system
Perez-Soler, Roman; Zou, Yiyi 1049491*Method for producing lactams
BASF 1049669*Azetidinecarboxamide derivatives for treating CNS disorders
Vernalis Research 1049670*Azetidinecaroxamide derivatives for the treatment of CNS disorders
Vernalis Research 1049671*Heterocyclic amidines as callicrein protease inhibitors
BASF 1049673*Chemokine receptor antagonists and methods of use thereof
Millennium Pharmaceuticals 1049675*4-aryl(piperidin-4-yl) aminobenzamides which bind to the delta-opioid receptor
Ortho-McNeil Pharmaceuticals 1049676*Novel sulphonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
Aventis Pharma Deutschland 1049677*Cyclohexyl and hetrocyclyl nuceloside derivatives, method for producing these derivatives, and the use of these derivatives and their oligomers or conjugates in pairing and/or testing systems
Aventis Research and Technologies 1049678*Sulphonamide derivatives for treatment of CNS disorders
SmithKline Beecham 1049679*Substituted aminoalkylideaminotriazenes as herbicides
Bayer; Nihon Bayer Agrochem 1049680*Oxazolidinone combinatorial libraries, compsns and methods of preparation
Versicor 1049682*Isothiazole carboxylic acid amies and the application thereof in order to protect plants
Bayer 1049683*Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compsns containing them
Dr Reddy's Research Foundation 1049684*Intermediates and methods useful in the semisynthesis of Paclitaxel and analogues
Indena 1049686*THF intermediates for annonaceous acetogenesis
Parker Hughes Institute 1049687*Benzothiadiazoles and derivatives
Novartis 1049694*2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Bayer 1049695*Triazolo-pyradazine derivatives as ligands for GABA receptors
Merck, Sharp and Dohme 1049696*Triazolo-pyradazine derivatives as ligands for GABA receptors
Merck, Sharp and Dohme 1049697*Triazolo-pyradazine derivatives as ligands for GABA receptors
Merck, Sharp and Dohme 1049698*Chemokine receptor antagonists and methods of use therefor
Millennium Pharmaceuticals 1049700*Tricyclic indolene substituted oxazolidinones
Bayer 1049701*Process for purifying a solution of an ampicillin pro-drug ester
AstraZeneca 1049702*New pentasaccharides, their methods of production and pharmaceutical compsns containing same
Sanofi-Synthelabo 1049706*Ustilipides, method for the production and the use thereof
Aventis Pharma Deutschland 1049707*Meth1 and meth2 polynucleotides and polypeptides
Human Genome Sciences 104970*Novel peptides having biological activity
Samyang Genex 1049709*Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
Regents of the University of Minnesota 1049710*Liposomes comprising peptide antigens derived from X protein of hepatitis B virus
Mogam Biotechnology Research Institute 1049711*Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS
Institut Pasteur 1049712*Secreted proteins and polynucleotides encoding them
Genetics Institute 1049714*RHO family antagonists and their use to block inhibition of neurite outgrowth
McKerracher, Lisa; Lehmann, Maxime 1049715*Purification of fibrinogen
CSL 1049716*Antibodies against human IL-12
F Hoffmann-La Roche 1049717*Monoclonal antibody anti alphaV-integrin and its use to inhibit alphaV-beta6-integrin attachment to fibronectin
Merck Patent 1049716*Cellulose ethers containing butenyl groups, and their use as protective colloids for polymerisation
Clariant 1049720*Synthetic polysaccharides, their method of production and pharmaceutical compsns containing them
Sanofi-Synthelabo 1049721*Pectin for use in paste-like materials, a method of preparing the same, paste-like materials comprising the pectin as well as the use thereof
Hercules 1049722*
